Camurus
Pre-clinicalCamurus is a Swedish science-led biopharmaceutical company committed to improving the lives of patients with severe and chronic diseases.
Founded
1991
Focus
Small Molecules
About
Camurus is a Swedish science-led biopharmaceutical company committed to improving the lives of patients with severe and chronic diseases.
Funding History
5Total raised: $270M
Debt$75MKreos CapitalSep 15, 2021
PIPE$75MUndisclosedFeb 15, 2021
Debt$30MKreos CapitalMar 15, 2019
IPO$40MUndisclosedMay 15, 2015
Company Info
TypePrivate
Founded1991
LocationLund, Sweden
StagePre-clinical
Contact
SIMILAR COMPANIES
Basic Genomics
Pre-clinical · Stockholm
2A Pharma
Phase 1 · Stockholm
Abliva
Pre-clinical · Lund
Affibody
Phase 1 · Solna
Alligator Bioscience
Phase 1 · Lund
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile